CardioNet Holter Monitoring
CardioNet is a well-known company in the field of ambulatory cardiac monitoring most notable for pioneering Mobile Cardiac Outpatient Telemetry (MCOT™) CardioNet changed their identity to BioTelemetry which was acquired by Philips Healthcare. So all CardioNet, BioTelemetry products & services are now under Philips Healthcare.
It has been a long road paving the industry for the newest form of cardiac monitoring called Mobile Cardiac Outpatient Telemetry. In an effort to sustain continued growth for MCT, CardioNet has made significant moves to establish a greater presence in the Holter Monitoring segment. Holter Monitoring is the standard diagnostic tool (in many cases) prior to the ordering Mobile Cardiac Telemetry. CardioNet acquired the leading OEM company of Holter & Event Monitoring devices called Braemar. CardioNet has recently continued this expansion with the acquisition of CardioCore and Biomedical Systems Service division.
Braemar is most known for manufacturing a 24 hour Holter monitor used by Burdick, Biomedical Systems and may others. Braemar is also a leading manufacture of Cardiac Event Monitors used by a large percentage of Event Monitoring services. The acquisition has brought CardioNet to the forefront of device technology making them a prominent company in the Holter Monitoring segment of ambulatory cardiac monitoring.
Competitive Advantage in Holter Monitoring
When we speak of CardioNet (BioTelemetry) as a Holter Monitoring company, we can conclude that they have a significant presence among all the existing Holter Monitoring companies. In addition to being a Holter Monitoring service company for many years, CardioNet has a huge competitive advantage in Holter Monitoring as they have access to many years of research, development of generations of Braemar Holter technology. Braemar has more than 2 decades of experience in Holter & Cardiac Event Monitoring making them a respectable leader.
Many speculate that CardioNet’s strategic moves in Holter Monitoring will result in huge success. Not only does it present greater access to more Holter Monitoring studies performed in the industry, but many industry experts believe that real-time, Mobile Cardiac Telemetry (MCT or MCOT™) studies can (potentially) replace the need for traditional Holter Monitoring. MCT presents a method of lowering overall healthcare costs as it acquires real time, continuous ECG data that may reduce or eliminate the need for other forms of ambulatory cardiac monitoring.
Holter Monitor Device Technology
As we discussed, Braemar has had many years of experience in the field of Holter Monitoring. Their devices are proven to be small, reliable and used by many different companies in the industry. CardioNet Holter analysis software employs the standard templating methodology used by many of the original Holter Monitoring companies. The analysis software is sound in detecting and assessing atrial fibrillation and common ectopic arrhythmias.
The fact that many others in the industry use the same monitor, the competitive advantage is somewhat diluted in terms of actual device technology. The major competitive advantage for CardioNet in Holter Monitoring relies mostly in the brand name and perceived quality of their products and services. For more information, click CardioNet / Braemar Holter Monitors
Company Accreditations
Independent Diagnostic Testing Facility (IDTF) by Centers for Medicare and Medicaid (CMS) in the state of Pennsylvania.
CardioNet has been awarded several regional contracts with various insurance and managed care organizations. Further, CardioNet has a Federal Supply Schedule Program which includes Tele-Home Care as well as ECG / Holter for its Mobile Cardiac Outpatient Telemetry (MCOT™) monitor
Legal & Safety Notice
CardioNet is a publicly traded (NASDAQ: BEAT) company under the name of Bio Telemetry. CardioNet has a sound reputation for providing clinically viable solutions for ambulatory cardiac monitoring. There is no public record of any legal notices related to the regulatory and/or manufacturing processes.
CardioNet has made big headlines of late with several legal disputes with patent infringement on their MCOT devices. For the latest updates, please visit Industry News
